An Open-Label Clinical Study Evaluating the Long-Term Safety of ALTU-135 for the Treatment of Patients with Exocrine Pancreatic Insufficiency due to Chronic Pancreat ...
|Effective start/end date||6/1/07 → 6/30/09|
- Altus Pharmaceuticals Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.